Transmission of chimeric HIV by mating in conventional mice: Prevention by pre-exposure antiretroviral therapy and reduced susceptibility during estrus

DMM Disease Models and Mechanisms

Volumn 6, Issue 5, 2013, Pages 1292-1298

  Hadas, Eran ^a   Chao, Wei ^a   He, Hongxia ^a   Saini, Manisha ^a   Daley, Eleen ^a,c   Saifuddin, Mohammed ^b,d   Bentsman, Galina ^a   Ganz, Eric ^a   Volsky, David J ^a   Potash, Mary Jane ^a  

^a Department of Medicine   (United States)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^c Metametrix Inc   (United States)

^d GEORGE MASON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; TENOFOVIR; VIRUS DNA; VIRUS RNA; ZALCITABINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL THERAPY; ARTICLE; CHIMERA; COITUS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTRUS; FEMALE; FEMALE GENITAL SYSTEM; GENE AMPLIFICATION; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION SENSITIVITY; INGUINAL LYMPH NODE; LYMPH NODE CELL; MALE; MATING; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEXUAL TRANSMISSION; SPLEEN CELL; T LYMPHOCYTE; VAS DEFERENS; VIRUS LOAD; VIRUS REPLICATION; VIRUS TRANSMISSION;

ANIMALS; ANTI-RETROVIRAL AGENTS; CHIMERA; COPULATION; DISEASE SUSCEPTIBILITY; ESTRUS; FEMALE; HIV; HIV INFECTIONS; HUMANS; MALE; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; SPLEEN; T-LYMPHOCYTES; VAGINA; VAS DEFERENS; VIRAL LOAD;

EID: 84883870005     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.012617     Document Type: Article

References (40)

1. Celum, C. and Baeten, J. M. (2012). Tenofovir-based pre-exposure prophylaxis for HIV prevention: evolving evidence. Curr. Opin. Infect. Dis. 25, 51-57.
2. Cranage, M., Sharpe, S., Herrera, C., Cope, A., Dennis, M., Berry, N. C. H., Ham, C., Heeney, J., Rezk, N., Kashuba, A. et al. (2008). Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel. PLoS Med. 5, e157, discussion e157.
3. Curtis, S. W., Clark, J., Myers, P. and Korach, K. S. (1999). Disruption of estrogen signaling does not prevent progesterone action in the estrogen receptor alpha knockout mouse uterus. Proc. Natl. Acad. Sci. USA 96, 3646-3651.
4. Denton, P. W., Estes, J. D., Sun, Z., Othieno, F. A., Wei, B. L., Wege, A. K., Powell, D. A., Payne, D., Haase, A. T. and Garcia, J. V. (2008). Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice. PLoS Med. 5, e16.
5. Denton, P. W., Othieno, F., Martinez-Torres, F., Zou, W., Krisko, J. F., Fleming, E., Zein, S., Powell, D. A., Wahl, A., Kwak, Y. T. et al. (2011). One percent tenofovir applied topically to humanized BLT mice and used according to the CAPRISA 004 experimental design demonstrates partial protection from vaginal HIV infection, validating the BLT model for evaluation of new microbicide candidates. J. Virol. 85, 7582-7593.
6. Gallichan, W. S. and Rosenthal, K. L. (1996). Effects of the estrous cycle on local humoral immune responses and protection of intranasally immunized female mice against herpes simplex virus type 2 infection in the genital tract. Virology 224, 487-497.
7. García-Lerma, J. G., Paxton, L., Kilmarx, P. H. and Heneine, W. (2010). Oral preexposure prophylaxis for HIV prevention. Trends Pharmacol. Sci. 31, 74-81.
8. Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., Goicochea, P., Casapía, M., Guanira-Carranza, J. V., Ramirez-Cardich, M. E. et al.; iPrEx Study Team (2010). Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N. Engl. J. Med. 363, 2587-2599.
9. Hadas, E., Borjabad, A., Chao, W., Saini, M., Ichiyama, K., Potash, M. J. and Volsky, D. J. (2007). Testing antiretroviral drug efficacy in conventional mice infected with chimeric HIV-1. AIDS 21, 905-909.
10. Heffron, R., Donnell, D., Rees, H., Celum, C., Mugo, N., Were, E., de Bruyn, G., Nakku-Joloba, E., Ngure, K., Kiarie, J. et al.; Partners in Prevention HSV/HIV Transmission Study Team (2012). Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect. Dis. 12, 19-26.
11. Im, E.-J., Hong, J. P., Roshorm, Y., Bridgeman, A., Létourneau, S., Liljeström, P., Potash, M. J., Volsky, D. J., McMichael, A. J. and Hanke, T. (2011). Protective efficacy of serially up-ranked subdominant CD8+ T cell epitopes against virus challenges. PLoS Pathog. 7, e1002041.
12. Jones, P. H., Mehta, H. V. and Okeoma, C. M. (2012). A novel role for APOBEC3: susceptibility to sexual transmission of murine acquired immunodeficiency virus (mAIDS) is aggravated in APOBEC3 deficient mice. Retrovirology 9, 50.
13. Kafka, J. K., Sheth, P. M., Nazli, A., Osborne, B. J., Kovacs, C., Kaul, R. and Kaushic, C. (2012). Endometrial epithelial cell response to semen from HIV-infected men during different stages of infection is distinct and can drive HIV-1-long terminal repeat. AIDS 26, 27-36.
14. Kelschenbach, J. L., Saini, M., Hadas, E., Gu, C.-J., Chao, W., Bentsman, G., Hong, J. P., Hanke, T., Sharer, L. R., Potash, M. J. et al. (2012). Mice chronically infected with chimeric HIV resist peripheral and brain superinfection: a model of protective immunity to HIV. J. Neuroimmune Pharmacol. 7, 380-387.
15. Lisco, A., Munawwar, A., Introini, A., Vanpouille, C., Saba, E., Feng, X., Grivel, J. C., Singh, S. and Margolis, L. (2012). Semen of HIV-1-infected individuals: local shedding of herpesviruses and reprogrammed cytokine network. J. Infect. Dis. 205, 97-105.
16. Marsden, H. M. and Bronson, F. H. (1964). Estrous synchrony in mice: alteration by exposure to male urine. Science 144, 1469.
17. Miller, C. J., Li, Q., Abel, K., Kim, E.-Y., Ma, Z.-M., Wietgrefe, S., La Franco-Scheuch, L., Compton, L., Duan, L., Shore, M. D. et al. (2005). Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus. J. Virol. 79, 9217-9227.
18. Mullen, T. E., Jr, Kiessling, R. L. and Kiessling, A. A. (2003). Tissue-specific populations of leukocytes in semen-producing organs of the normal, hemicastrated, and vasectomized mouse. AIDS Res. Hum. Retroviruses 19, 235-243.
19. Münch, J., Rücker, E., Ständker, L., Adermann, K., Goffinet, C., Schindler, M., Wildum, S., Chinnadurai, R., Rajan, D., Specht, A. et al. (2007). Semen-derived amyloid fibrils drastically enhance HIV infection. Cell 131, 1059-1071.
20. Okada, Y., Abe, E., Komuro, K. and Mizuochi, T. (1998). Heterosexual transmission of a murine AIDS virus. J. Virol. 72, 2541-2543.
21. Pilcher, C. D., Joaki, G., Hoffman, I. F., Martinson, F. E. A., Mapanje, C., Stewart, P. W., Powers, K. A., Galvin, S., Chilongozi, D., Gama, S. et al. (2007). Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection. AIDS 21, 1723-1730.
22. Portis, J. L., McAtee, F. J. and Hayes, S. F. (1987). Horizontal transmission of murine retroviruses. J. Virol. 61, 1037-1044.
23. Potash, M. J., Chao, W., Bentsman, G., Paris, N., Saini, M., Nitkiewicz, J., Belem, P., Sharer, L., Brooks, A. I. and Volsky, D. J. (2005). A mouse model for study of systemic HIV-1 infection, antiviral immune responses, and neuroinvasiveness. Proc. Natl. Acad. Sci. USA 102, 3760-3765.
24. Quayle, A. J., Xu, C., Mayer, K. H. and Anderson, D. J. (1997). T lymphocytes and macrophages, but not motile spermatozoa, are a significant source of human immunodeficiency virus in semen. J. Infect. Dis. 176, 960-968.
25. Robertson, S. A. (2005). Seminal plasma and male factor signalling in the female reproductive tract. Cell Tissue Res. 322, 43-52.
26. Roshorm, Y., Hong, J. P., Kobayashi, N., McMichael, A. J., Volsky, D. J., Potash, M. J., Takiguchi, M. and Hanke, T. (2009). Novel HIV-1 clade B candidate vaccines designed for HLA-B*5101(+) patients protected mice against chimaeric ecotropic HIV-1 challenge. Eur. J. Immunol. 39, 1831-1840.
27. Sabatté, J., Remes Lenicov, F., Cabrini, M., Rodriguez Rodrigues, C., Ostrowski, M., Ceballos, A., Amigorena, S. and Geffner, J. (2011). The role of semen in sexual transmission of HIV: beyond a carrier for virus particles. Microbes Infect. 13, 977-982.
28. Saini, M., Hadas, E., Volsky, D. J. and Potash, M. J. (2007). Vaccine-induced protection from infection of mice by chimeric human immunodeficiency virus type 1, EcoHIV/NL4-3. Vaccine 25, 8660-8663.
29. Sharkey, D. J., Macpherson, A. M., Tremellen, K. P., Mottershead, D. G., Gilchrist, R. B. and Robertson, S. A. (2012a). TGF-β mediates proinflammatory seminal fluid signaling in human cervical epithelial cells. J. Immunol. 189, 1024-1035.
30. Sharkey, D. J., Tremellen, K. P., Jasper, M. J., Gemzell-Danielsson, K. and Robertson, S. A. (2012b). Seminal fluid induces leukocyte recruitment and cytokine and chemokine mRNA expression in the human cervix after coitus. J. Immunol. 188, 2445-2454.
31. Sheehy, A. M., Gaddis, N. C., Choi, J. D. and Malim, M. H. (2002). Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418, 646-650.
32. Smith, S. M., Mefford, M., Sodora, D., Klase, Z., Singh, M., Alexander, N., Hess, D. and Marx, P. A. (2004). Topical estrogen protects against SIV vaginal transmission without evidence of systemic effect. AIDS 18, 1637-1643.
33. Sun, Z., Denton, P. W., Estes, J. D., Othieno, F. A., Wei, B. L., Wege, A. K., Melkus, M. W., Padgett-Thomas, A., Zupancic, M., Haase, A. T. et al. (2007). Intrarectal transmission, systemic infection, and CD4+ T cell depletion in humanized mice infected with HIV-1. J. Exp. Med. 204, 705-714.
34. UNAIDS (2012). Report on the Global AIDS Epidemic, pp. 34. Geneva: UNAIDS.
35. Vishwanathan, S. A., Guenthner, P. C., Lin, C. Y., Dobard, C., Sharma, S., Adams, D. R., Otten, R. A., Heneine, W., Hendry, R. M., McNicholl, J. M. et al. (2011). High susceptibility to repeated, low-dose, vaginal SHIV exposure late in the luteal phase of the menstrual cycle of pigtail macaques. J. Acquir. Immune Defic. Syndr. 57, 261-264.
36. Wawer, M. J., Gray, R. H., Sewankambo, N. K., Serwadda, D., Li, X., Laeyendecker, O., Kiwanuka, N., Kigozi, G., Kiddugavu, M., Lutalo, T. et al. (2005). Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J. Infect. Dis. 191, 1403-1409.
37. Whitten, W. K. (1956). Modification of the oestrous cycle of the mouse by external stimuli associated with the male. J. Endocrinol. 13, 399-404.
38. Wira, C. R. and Fahey, J. V. (2008). A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle. AIDS 22, 1909-1917.
39. Witvrouw, M., Pannecouque, C., Switzer, W. M., Folks, T. M., De Clercq, E. and Heneine, W. (2004). Susceptibility of HIV-2, SIV and SHIV to various anti-HIV-1 compounds: implications for treatment and postexposure prophylaxis. Antivir. Ther. 9, 57-65.
40. Wortis, H. H., Nehlsen, S. and Owen, J. J. (1971). Abnormal development of the thymus in "nude" mice. J. Exp. Med. 134, 681-692.